Choi, A. Y., M. S. Mulvihill, J. Weber, H. Lee, M. L. Cox, B. A. Yerokun, M. Kuchibhatla, J. A. Klapper, and M. G. Hartwig. “Center Variability in Organ Offer Acceptance and Waitlist Mortality in Lung Transplantation.” In The Journal of Heart and Lung Transplantation, 38:S103–4. Elsevier BV, 2019. https://doi.org/10.1016/j.healun.2019.01.243.
Michael Mulvihill, MD
Clinical and Research Interests
End-stage heart and lung failure
Honors and Awards
2012 AOA Award - James B. D. Palmer GSK Memorial Scholarship Fund Award
2015 Feagin Scholar
Barac, Y. D., M. Mulvihill, O. Jawitz, J. Haney, J. Klapper, M. Daneshmand, and M. Hartwig. “High Calculated Panel Reactive Antigen (cPRA) is Associated with Decreased Rates of Transplantation and Increased Waitlist Mortality in Lung Transplantation: A UNOS/OPTN Registry Analysis.” In The Journal of Heart and Lung Transplantation, 38:S148–S148. Elsevier BV, 2019. https://doi.org/10.1016/j.healun.2019.01.353.
Jawitz, O. K., V. Raman, Y. Barac, M. Mulvihill, C. Moore, A. Choi, M. Hartwig, and J. Klapper. “Time from Lung Transplant Donor Brain Death to Cross Clamp: An Analysis of the UNOS Registry.” In The Journal of Heart and Lung Transplantation, 38:S190–S190. Elsevier BV, 2019. https://doi.org/10.1016/j.healun.2019.01.459.
Choi, A. Y., O. K. Jawitz, V. Raman, Y. Barac, M. S. Mulvihill, C. Moore, and M. G. Hartwig. “Unfavorable Donor after Cardiac Death Characteristics in Lung Transplantation: An Analysis of the UNOS Registry.” In The Journal of Heart and Lung Transplantation, 38:S149–50. Elsevier BV, 2019. https://doi.org/10.1016/j.healun.2019.01.357.
Mulvihill, Michael S., Kannan P. Samy, Qimeng A. Gao, Robin Schmitz, Robert P. Davis, Brian Ezekian, Francis Leopardi, et al. “Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study..” Am J Transplant, March 20, 2019. https://doi.org/10.1111/ajt.15365.
Watson, J., M. S. Mulvihill, M. L. Cox, L. Rich, C. R. Wolfe, A. Gray, and M. G. Hartwig. “Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.” In Clinical Transplantation, Vol. 33, 2019. https://doi.org/10.1111/ctr.13476.
Watson, Joshua, Michael S. Mulvihill, Morgan L. Cox, Lauren Rich, Cameron R. Wolfe, Alice Gray, and Matthew G. Hartwig. “Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation..” Clin Transplant 33, no. 3 (March 2019). https://doi.org/10.1111/ctr.13476.
Cox, Morgan L., Michael S. Mulvihill, Ashley Y. Choi, Muath Bishawi, Asishana A. Osho, John C. Haney, Mani Daneshmand, Jacob A. Klapper, Cameron R. Wolfe, and Matthew Hartwig. “Implications of declining donor offers with increased risk of disease transmission on waiting list survival in lung transplantation..” J Heart Lung Transplant 38, no. 3 (March 2019): 295–305. https://doi.org/10.1016/j.healun.2018.12.012.
Bendersky, Victoria A., Michael S. Mulvihill, Babatunde A. Yerokun, Brian Ezekian, Robert P. Davis, Matthew G. Hartwig, and Andrew S. Barbas. “Elevated Donor Hemoglobin A1C Impairs Kidney Graft Survival From Deceased Donors With Diabetes Mellitus: A National Analysis..” Exp Clin Transplant, January 21, 2019. https://doi.org/10.6002/ect.2017.0322.